Trials / Completed
CompletedNCT02935374
Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children
Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- All
- Age
- 6 Months – 7 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, controlled trial studying the effects of various antimicrobial treatments on the intestinal microbiome of small children. The participating children with acute otitis media are treated wither with amoxicillin, amoxicillin-clavulanate or without antibiotics. The children with allergy to amoxicillin receive a course of macrolide and they will be monitored as a separate group. The main outcomes of this trial are the changes in the intestinal microbiome after the treatment.
Detailed description
Antimicrobial treatment of acute otitis media has been proven efficacious in children. It has been suggested that antimicrobial treatment makes a lot of harm to intestinal microbiome and may thus have effects on the child's health and wellbeing. However, data on these changes and their magnitude is scanty. This is a randomized, controlled trial studying the effects of various antimicrobial treatments on the intestinal microbiome of small children. The participating children with acute otitis media are treated wither with amoxicillin, amoxicillin-clavulanate or without antibiotics. The children with allergy to amoxicillin receive a course of macrolide and they will be monitored as a separate group. The main outcomes of this trial are the changes in the intestinal microbiome after the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amoxicillin | The children with acute otitis media will be treated with amoxixillin mixture, 100mg/ml, 40mg/kg/d, divided to two daily doses for 7 days. |
| DRUG | Amoxicillin-Potassium Clavulanate | The children with acute otitis media will be treated with amoxixillin-clavulanate mixture, 80mg/ml, 45mg/kg/d, divided to two daily doses for 7 days. |
| DRUG | Macrolide | The children with acute otitis media with a know allergy to amoxicillin or amoxicillin-clavulanate will be treated with macrolide and monitored separately |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2016-10-17
- Last updated
- 2022-08-11
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02935374. Inclusion in this directory is not an endorsement.